Curry, William T
Mayo Clinic
From Massachusetts General Hospital Cancer Center, Harvard Medical School (P.K.B., E.R.G., S.T., J.T., A.J.I., W.T.C., D.P.C., H.A.S., F.G.B.), Dana-Farber Cancer Institute (D.A.R.), and Brigham and Women's Hospital, Harvard Program in Therapeutic Science,
Citations 1
BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Brastianos, Priscilla K. , Twohy, Erin , Geyer, Susan, Gerstner, Elizabeth R. , Tabrizi, Shervin , Kabat, Brian, Thierauf, Julia , Ruff, Michael W. , Bota, Daniela A. , Reardon, David A. , Cohen, Adam L. , Fuente, Macarena I. de la, Lesser, Glenn J. , Campian, Jian , Agarwalla, Pankaj K., Kumthekar, Priya , Mann, Bhupinder, Vora, Shivangi, Knopp, Michael, Iafrate, A. John , Brown, Paul D. , Barker, Fred G., De La Fuente, Macarena I, Curry, William T, Cahill, Daniel P. , Kaufmann, Timothy J. , Knopp, Michael V. , Curry, William T. , Shih, Helen A. , Santagata, Sandro , Galanis, Evanthia
New England Journal of Medicine | July 12, 2023 | Volume: 389 | Issue: 2 | Pages: 118-126
